Search Results
Jan 05, 2026, 09:00 ET Cambium Secures $100 Million Series B to Accelerate the Discovery and Scaling of Advanced Materials
announced a $100 million Series B financing led by 8VC, with participation from MVP Ventures, Lockheed Martin Ventures, GSBackers, Veteran Ventures Capital, J17 Ventures, Vanderbilt University, Alumni Ventures, Gaingels, Inevitable Ventures, JACS Capital, Jackson Moses, and other individuals and family offices.
More news about: Cambium Biomaterials, Inc
Jan 05, 2026, 08:37 ET First-of-its-Kind Study Shows Visibility into Real-Time Spinal Cord Stimulation Utilization and Supports a New Standard of Long-Term Device Management
Pope J, Levy RM, Gilligan C, et al. Real-World Spinal Cord Stimulation Utilization and Implant Status: An Analysis of a Novel, Real-Time, Remote Monitoring Database. Neuromodulation. 2025Amirdelfan K, Antony A, Levy R, Pope J, Falowski S, Naidu R, Patel
More news about: BIOTRONIK Neuro
Jan 05, 2026, 08:05 ET SynuSight Biotech, ABLi Therapeutics and XingImaging Announce Strategic Collaboration to Implement Alpha-Synuclein PET Imaging into Clinical Trials Evaluating Risvodetinib as a Disease-modifying Therapy for Parkinson's disease
18F‑FD4 received a $3.84 million research grant from the Michael J. Fox Foundation for Parkinson's Research (MJFF)—the world's largest nonprofit philanthropy of PD research—to support its U.S. clinical registration
More news about: SynuSight Biotech
Jan 05, 2026, 08:00 ET Kenai Therapeutics Receives $8M Grant from California Institute for Regenerative Medicine (CIRM) to Advance RNDP-001 for Treatment of Idiopathic Parkinson's Disease
to cure neurological conditions, today announced that the California Institute for Regenerative Medicine (CIRM) awarded an $8 million grant to Howard J. Federoff, M.D., Ph.D., Kenai's Co-Founder, Chief Medical Officer, Executive Vice President of Corporate Medicine and Principal Investigator. This funding
More news about: Kenai Therapeutics/BIOCOM
Jan 05, 2026, 08:00 ET PKF O'Connor Davies Welcomes Bowman & Company
Kevin J. Keane, Chief Executive Officer at PKF O'Connor Davies. "As we continue to strategically expand our footprint in key markets, we look forward to leveraging
More news about: PKF O’Connor Davies
Jan 05, 2026, 08:00 ET Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
References: Wharton S, Lingvay I, Bogdanski P, et al. Oral semaglutide 25 mg in adults with overweight or obesity. N Engl J Med. 2025; 393:1077-1087. DOI: 10.1056/NEJMoa2500969. Centers for Disease Control and Prevention. Adult obesity facts. Last accessed: December
More news about: NOVO NORDISK INC.
Jan 05, 2026, 07:30 ET Retired Lt. Gen. Omar Jones Joins GreenGen as Advisory Board Chair
GreenGen, a global leader in energy and resilience solutions, today announced that retired U.S. Army Lt. Gen. Omar J. Jones IV has joined the company as Chair of its Advisory Board. The appointment comes as GreenGen experiences unprecedented growth in its public sector
More news about: GreenGen
Jan 05, 2026, 07:00 ET Muslim Smart Wearables Enter the Global CES Spotlight as iQIBLA Unveils Third-Generation Devices
the growing scale of Muslim-focused consumer technology within the global wearables sector.One of the products on display is the Zikr Ring J03, iQIBLA's third-generation smart ring and the first to integrate Qibla direction into a ring-based wearable. Designed for discreet, continuous
More news about: iQIBLA
Jan 05, 2026, 07:00 ET Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
QC, Jan. 5, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that Thomas J. Appio, Chief Executive Officer, will participate at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California on January
More news about: Bausch Health Companies Inc.
Jan 05, 2026, 07:00 ET RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
release ondansetron improves stool consistency and symptomatology in diarrhea-predominant irritable bowel syndrome: A randomized, double-blind trial. Am J Gastroenterol 2020;115:1466-73.9 Acute gastroenteritis and gastritis are characterized by inflammation of the mucus membranes of the
More news about: RedHill Biopharma Ltd.
Jan 05, 2026, 06:50 ET Protalix BioTherapeutics Letter to Stockholders
Punzi L, Scagnellato L, Galozzi P, et al. Gout: one year in review 2025. Clin Exp Rheumatol. 2025;43(5):799–808.2 Jacobsen J, Shattler K. Gout Statistics & Facts 2025. HealthCanal. Published November 28, 2023.3 American Arthritis Foundation. Millions
More news about: Protalix BioTherapeutics, Inc.
Jan 05, 2026, 05:45 ET Jacobs to Acquire Remaining Stake in PA Consulting
Jacobs (NYSE: J) and
More news about: Jacobs
Jan 05, 2026, 05:00 ET CivicaScript announces availability of low-cost insulin and biosimilar for chronic inflammatory conditions in the US
New Year by expanding access to two important biosimilars that can help lower costs for patients and health plans," said CivicaScript President Brent J. Eberle. "Our growing portfolio shows that putting patients first isn't just the right thing to do – it's a proven path to delivering affordable generics
More news about: CivicaScript
Jan 05, 2026, 04:47 ET Curasight to hold Meetings in San Francisco During J.P. Morgan Healthcare Conference Week
https://news.cision.com/curasight/r/curasight-to-hold-meetings-in-san-francisco-during-j-p--morgan-healthcare-conference-week,c4288616The following files are available for download:
More news about: Curasight
Jan 05, 2026, 04:45 ET Curasight to hold Meetings in San Francisco During J.P. Morgan Healthcare Conference Week
https://news.cision.com/curasight/r/curasight-to-hold-meetings-in-san-francisco-during-j-p--morgan-healthcare-conference-week,c4288616The following files are available for download:
More news about: Curasight
Jan 05, 2026, 03:11 ET Leadership Beyond Boundaries: India's Visionaries Driving Multi-Sector Transformation
without compromising standards. Guided by a clear vision of innovation and reliability.Master J. S. Krithvik Arya: A Young Prodigy Redefining Early-Age Sports Excellence in India Master J. S. Krithvik Arya, a five-year-old sporting prodigy from Tamil Nadu, is rapidly emerging as one of India's
More news about: Kiteskraft Productions LLP
Jan 05, 2026, 03:01 ET MSI Unveils EZgo, a Rugged 9.6kW Portable EV Charger Built to Charge Anywhere
options and delivers up to 40A / 9.6kW to help drivers recharge faster when a 240V outlet is available. With a 25-foot charging connector and Type 1 (J1772) or NACS options, EZgo is built to fit a wide range of EVs and daily driving needs.Smart charging, without the "app-first" headacheUnlike
More news about: MSI
Jan 04, 2026, 19:46 ET Des combattants chinois méconnus sur le champ de bataille européen | Frères d'armes ⑤
gens pensent que le jour J a été une opération menée par les Américains », a déclaré Sacha Marsac, responsable des opérations (France) du Mémorial britannique de Normandie. « Nous ne nous attendions pas non plus à ce que des soldats chinois participent à l'opération du jour J. »Selon des documents
More news about: South
Jan 04, 2026, 09:00 ET homerunPET to Showcase Breakthrough CS106 Self-Cleaning Litter Box and New AI Camera Add-On at CES 2026
water fountains, automated feeders, and pet dryers designed for modern homes around the world.For media inquiries, please contact:Rachel J.[email protected]
More news about: Homerunpet
Jan 02, 2026, 12:00 ET Bitdeer Technologies Group (BTDR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
2024 and November 10, 2025, Defendants failed to disclose to investors that: (1) the SEAL04 chip projected to have a chip-level energy efficiency of 5 J/TH would be ready for use in the A4 rigs with an expected mass production to begin in the second quarter 2025; and (2) as a result, Defendants' positive
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Jan 02, 2026, 11:35 ET S&T Bancorp, Inc. to Host Fourth Quarter Earnings Conference Call and Webcast
detailing the company's fourth quarter and full year 2025 earnings will be held live via webcast at 1:00 p.m. ET, Thursday, January 22, 2026. Christopher J. McComish, chief executive officer, David G. Antolik, president, and Mark Kochvar, chief financial officer, will conduct the conference call. The public
More news about: S&T Bancorp, Inc.
Jan 02, 2026, 09:00 ET j5create Unveils AERO DROP CrossLink Wireless Dongle to Bridge the Gap Between iPhone/iPad and Windows at CES 2026
https://www.amazon.com/dp/B0G2X3ZF3K). Availability on j5create.com and other regional Amazon marketplaces will follow.j5create at CESFor firsthand experiences of j5create's latest innovations, including the AERO DROP CrossLink Wireless Dongle, visitors to CES 2026 are invited to visit j5create's booth from January
More news about: j5create
Jan 02, 2026, 09:00 ET APUS Celebrates Top Scholars for Outstanding Academic Achievement
Lynch Ryan Lynch Charlotte Lyons Dawn Lytle Kathryne Macdonald David Mace Eduardo Macias J Mack Maurice Mack Jacob Mackay Lexie Mackay Sanya Mackenzie Brooke Mackrell Janella Micah Madamba Jason
More news about: American Public University System
Jan 02, 2026, 08:00 ET J Franco named ABWA's Business Woman of the Year
marketing."J is the epitome of an ABWA Top Ten Business Woman and member," said Elizabeth Johnson, CAE, Executive Director of ABWA. "She is successful and professional, while also striving for more for herself, her community, and her ABWA chapter. We are proud to have J represent our organization
More news about: American Business Women's Association
Jan 02, 2026, 01:00 ET Ecovyst Completes Sale of Advanced Materials & Catalysts Segment to Technip Energies
Materials & Catalysts segment creates significant value for our stockholders by allowing us to realize the intrinsic value of the business," said Kurt J. Bitting, Ecovyst's Chief Executive Officer. "Net proceeds from the sale will provide for significantly reduced leverage and enhanced financial flexibility
More news about: Ecovyst Inc.